Turning Point Therapeutics - Ownership and Business Overview

Life ScienceCompany

Turning Point Therapeutics Ownership

Who owns Turning Point Therapeutics?

Turning Point Therapeutics is owned by Bristol-Myers Squibb and HBM Partners AG. It was acquired on June 3, 2022.

Is Turning Point Therapeutics PE-backed?

Yes. Turning Point Therapeutics is owned by private equity investors Bristol-Myers Squibb and HBM Partners AG.

Turning Point Therapeutics Business Overview

Where is Turning Point Therapeutics headquartered?

Turning Point Therapeutics is headquartered in San Diego, California.

What is Turning Point Therapeutics’ revenue?

Turning Point Therapeutics disclosed revenue of 31M USD for 2021 and 25M USD for 2020.

What sector is Turning Point Therapeutics in?

Turning Point Therapeutics is a life science company.

When was Turning Point Therapeutics founded?

Turning Point Therapeutics was founded in 2013.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 288 acquisitions of life science companies in 2022, including 35 acquisitions by private equity firms, and 253 by strategics.

Turning Point Therapeutics

Turning Point Therapeutics, Inc.

10628 Science Center Drive Suite 200,
San Diego, California 92121
United States,
www.tptherapeutics.com

Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of investigational drugs designed to address key limitations of existing cancer therapies. The company’s lead drug candidate, repotrectini, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung cancer and advanced solid tumors. Turning Point Therapeutics was formed in 2013 and is based in San Diego, California.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.